Board certified in pediatric hematology/oncology and pediatrics by the American Board of Pediatrics, Dr. Vonda Crouse has been with Children’s Hospital Central California for 21 years. Dr. Crouse has been a participant in Children’s Oncology Group (COG) since 1980. Since joining Children’s in 1987, she has served as Responsible Investigator and has been Principle Investigator in COG since 2000. An expert in treating childhood cancer, she has nearly 30 years of clinical research in pediatric oncology.

Dr. Crouse belongs to several professional societies including the American Academy of Pediatrics and the American Society of Pediatric Hematology and Oncology. Her work has been published in professional journals including Pediatrics and the American Journal of Epidemiology.

Prior to joining Children’s, Dr. Crouse was a pediatric oncologist at The Children’s Hospital in Denver, Colorado and Assistant Professor of Pediatrics at the University of Colorado Health Sciences.

A graduate of the University of Southern California (USC), Dr. Crouse completed her pediatric internship and residency at Children’s Hospital of Los Angeles in Los Angeles, California, where she served as Chief Resident. She is fellowship trained in pediatric hematology/oncology by Children’s Hospital of Los Angeles.

Publications

Kwan ML, Metayer C, Crouse V, Buffler PA. “Maternal illness and drug/medication use during the period surrounding pregnancy and risk of childhood leukemia among offspring.” Am J Epidemiol. 2007; 165(1):27-35.
PMID: 17035343

Smith TL, Pullen GT, Crouse V, Rosenberg J, Jarvis WR. “Bloodstream infections in pediatric oncology outpatients: a new healthcare systems challenge.” Infect Control Hosp Epidemiol. 2002; 23(5):239-43.
PMID: 12026147

Lee YS, Kristovich KM, Ducore JM, Vichinsky E, Crouse VL, Glader BE, Amylon MD. “Bone marrow transplant in thalassemia. A role for radiation?” Ann N Y Acad Sci. 1998; 850:503-5.
PMID: 9668596

Lewis AB, Crouse VL, Evans W, Takahashi M, Siegel SE. “Recovery of left ventricular function following discontinuation of anthracycline chemotherapy in children.” Pediatrics. 1981; 68(1):67-72.
PMID: 6941210